PRECLINICAL MODELS OF BREAST CANCER

描述（申请人提供）：从实验室到临床是一段很长的路，讨论会缩短这段路。 整个小鼠和人类基因组的公布具有巨大的科学和医学研究潜力，从而导致开发用于治愈人类乳腺癌的新药和新的治疗策略。 本次会议将于2003年11月1日至11月4日在加州萨克拉门托的萨克拉门托会议中心举行。 该会议旨在加速人类乳腺癌小鼠模型在临床前试验中的应用。 第24届国际乳腺癌研究协会大会将汇集国际社会讨论临床前模型的主题。 该会议由美国国家癌症研究所人类癌症小鼠模型联盟和SPORE-MMHCC乳腺癌联合委员会共同主办。 它是由加州大学，戴维斯卫生系统，加州大学戴维斯分校癌症中心，继续教育和加州大学戴维斯分校比较医学和小鼠生物学计划中心共同主办。 一些乳腺癌倡导团体表示他们渴望参与，加州大学戴维斯分校和萨克拉门托加州州立大学的少数民族科学项目将参与其中。 还将鼓励工业赞助。 为了实现基础科学家，临床医生，工业和政府的合作与协作，会议将为每个小组提供时间。 为了强调临床前试验的转化目标，会议将为每个小组提供时间。 为了强调临床前试验的转化目标，会议还将包括临床医生和乳腺癌倡导者的积极参与。 因此，工业的需要和利益将得到强调，并在讲台上得到代表。 该计划将包括全体会议，分组会议，展览和海报会议。 预计将有500至800人参加。 会前研讨会将为大约30名与会者提供实践培训机会。 工作坊的主题是“高密度表型：一天内从老鼠到分子！“它将允许学生检查和比较目前可用的最好和最快的表型分析技术。

DESCRIPTION (provided by applicant): It is a long way from the laboratory to the clinic, discussion will shorten it. The publication of the entire mouse and human genomes has enormous potential for scientific and medical research leading to the development of new drugs and new therapeutic strategies for the cure of human breast cancer. This meeting will be held from November 1 to November 4, 2003 at the Sacramento Convention Center, Sacramento, California. The meeting is designed to hasten the application of mouse models of human breast cancer in preclinical trials. The 24th Congress of the International Associate for Breast Cancer Research will bring together the international community for discussions focused on the subject of preclinical models. The meeting is co-sponsored by the National Cancer Institute Mouse Models of Human Cancer Consortium and the Joint SPORE-MMHCC Breast Cancer Committee. It is co-hosted by the University of California, Davis Health System, the UC Davis Cancer Center, Continuing Education and the UC Davis Center for Comparative Medicine and Mouse Biology Program. A number of Breast Cancer Advocate Groups have indicated their eagerness to participate and minority science programs from UC Davis and from California State University, Sacramento will be involved. Industrial sponsorship will also be encouraged. To achieve the cooperation and collaboration of basic scientists, clinicians, industry, and government, the meeting will provide time for each group. To emphasize the translational objective of pre-clinical trials, the meeting will provide time for each group. To emphasize the translational objective of pre-clinical trials, the meeting will also include the active participation of clinicians and breast cancer advocates. Perforce, the needs and interests of industry will be emphasized and represented from the podium. The program will include Plenary Sessions, Breakout Sessions, Exhibits and Poster Sessions. The projected attendance is 500 to 800 participants. A pre-meeting workshop will provide hands-on training opportunities for approximately 30 participants. The theme of the workshop is "High Throughput Phenotyping: From Mouse to Molecule in One Day!" It will allow the student to examine and compare the best and fastest phenotyping technology currently available.